Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

CycloSPORINE Capsules

Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities

Terminated Impurity / degradation Amerisource Health Services NDC 68084-921-25 D-0490-2017
Class III · Low risk

Levofloxacin Ophthalmic Solution

Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18 month stability time point.

Terminated Impurity / degradation Actavis Inc NDC 50383-283-05 D-0514-2017
Class II · Moderate risk

Indocin (Indomethacin)

Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.

Terminated Impurity / degradation G & W Laboratories, Inc. NDC 42211-0102-43 D-0501-2017

Recalls by year